NCT02555189
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02555189 |
| Title | Enzalutamide With and Without Ribociclib for Metastatic, Castrate-Resistant, Chemotherapy-Naive Prostate Cancer That Retains RB Expression |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Sidney Kimmel Cancer Center at Thomas Jefferson University |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
CKB BOOST